Received Oct 13, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | Y013009 | IM / RA |
Patient presented to pharmacy with complaint of itchy rash spreading at site of vaccination that was administered 5 days previous (October 8, 2025). RPh on duty invited patient into counseling room so that RPh could assess her condition. RPh noted red rash approximately 3in X 6in size. Rash was very hot to touch. Assessment - patient was experiencing an active reaction at the site of vaccine administration. RPh reviewed SCT and profile to confirm vaccine and location of administration. RPh reviewed actions to be performed by RPh which included reporting to VAERS and contacting her PCP. Patient was advised to seed immediate medical attention by her PCP or Emergency medical facility.
NONE
NONE
NA
NKDA
NA